- About Stallergenes
- Key figures
Stallergenes : an international leader in desensitisation therapy:
- Nearly 500 000 patients are treated yearly by Stallergenes
- Near 700 men and women are employed by Stallergenes throughout the world.
- Stallergenes devotes 16% of its 2007 sales to the research and development for better therapeutic solutions.
- Stallergenes has initiated and conducted nearly 30 controlled clinical studies since 2000, including nearly 2700 patients in total.
Key Figures 2007
- Consolidated Sales
- Breakdown of Sales
- Profit before R&D
- EBIT and R&D
- Net Profit
- Net financial borrowings and EBITDA
- Capital expenditure
- Workforce as at 31.12
